Reduction of cow’s milk protein allergy risk by using a formula with partially hydrolyzed whey protein.
- Conditions
- risk reduction, cow's milk allergy
- Registration Number
- NL-OMON25443
- Lead Sponsor
- Dr. Rouzha Pancheva, Prof. Dr. Paraskev Stoyanov Medical University of Varna, 55 Marin Drinov Str., 9002 Varna, BulgariaDr Nicolaos Nicolaou, Asthma and Allergy Center LTD, 24 Nafpliou Street, St Raphael Court, 2nd floor, No. 21, 3025, Limassol, CyprusDr. Nicoletta Iacovidou, Magginio Maternity Clinic, Aretaieio Hospital”, Athens, Greece
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 750
Inclusion Criteria
•Gestational age ≥37 weeks
•Younger than 5 days (with regard to time to decide on participation)
Exclusion Criteria
•Severe acquired or congenital diseases, mental or physical disorders, symptoms of allergy according to the SCORAD or ComiSS forms
•Gestational age <37 weeks
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proven cow's milk protein allergy: atopic dermatitis and total allergic manifestations
- Secondary Outcome Measures
Name Time Method Growth in weight, length and head circumference